John Dundon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. John Dundon | Medicine and Dentistry | Research Excellence Award 

Orthopedic Research Institute of New Jersey | United States

Dr. John M. Dundon is a board-certified orthopedic surgeon and clinician–scientist with a distinguished research profile focused on adult reconstruction, total hip and knee arthroplasty, surgical innovation, and value-based orthopedic care. As a Full Partner at Tri-County Orthopedics and previously at the Orthopedic Institute of New Jersey, Dr. Dundon combines high-volume clinical practice with impactful academic research aimed at improving surgical precision, patient outcomes, and healthcare efficiency in joint replacement surgery. A central theme of Dr. Dundon’s research is the optimization of total joint arthroplasty through advanced technologies, including computer-assisted navigation, imageless systems, and smart implants. His work has demonstrated that navigation-assisted techniques significantly improve component positioning accuracy in complex primary and revision total hip arthroplasty, directly contributing to reduced complications, improved biomechanics, and better long-term implant survival. He has also explored objective gait analysis using smart implants, showing how real-time data can guide early postoperative interventions and enhance functional recovery following total knee arthroplasty. Dr. Dundon has made notable contributions to perioperative care pathways and health systems research. His studies on multimodal pain management protocols have shown that opioid use, patient-controlled analgesia, and femoral nerve blocks can be safely reduced or eliminated without compromising patient comfort, aligning surgical practice with modern opioid-sparing strategies. Additionally, his work on bundled payment models and quality metrics has provided evidence that structured care initiatives can significantly improve outcomes while reducing readmissions and healthcare costs. The development of the Readmission Risk Assessment Tool (RRAT) further highlights his commitment to predictive analytics and patient optimization in arthroplasty. His research portfolio also addresses implant biomechanics, tribocorrosion, femoral stem sizing, leg-length discrepancy correction, and postoperative imaging utilization, reflecting a comprehensive approach to both technical and clinical challenges in orthopedic surgery. Dr. Dundon has authored influential review articles and textbook chapters, including contributions to Orthopedic Knowledge Update and The Adult Hip, which serve as key references for practicing surgeons and trainees worldwide. With an extensive record of peer-reviewed publications, national and international presentations, and leadership roles within major orthopedic societies such as the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, Dr. Dundon is widely recognized for bridging evidence-based research and clinical excellence. His research profile reflects sustained innovation, interdisciplinary collaboration, and a clear commitment to advancing the safety, effectiveness, and value of modern joint replacement surgery.

Citation Metrics (Scopus)

1000
600
400
200
50
0

Citations
641

i10index
20

h-index
9

Citations

i10-index

h-index

View Scopus Profile

Featured Publications

Magdalena Sobieska | Physiotherapy | Research Excellence Award

Published on by Invention Awards

Prof. Magdalena Sobieska | Physiotherapy | Research Excellence Award

Prof. Magdalena Sobieska | Poznań University of Medical Sciences | Poland

Dr. Magdalena Sobieska is a distinguished rehabilitation and physiotherapy specialist at the Poznań University of Medical Sciences, widely recognized for her deep expertise in immunology, clinical diagnostics, and physical medicine. She has held influential academic and leadership roles that have significantly strengthened physiotherapy education, clinical practice, and international program development within her institution. A prolific and impactful researcher, Dr. Sobieska has contributed substantially to multiple domains intersecting immunology and rehabilitation. Her scientific work encompasses the study of acute phase proteins as sensitive indicators of immune activation following physical exercise, stress, and physiotherapeutic interventions. She has also advanced understanding of eosinophil activation mechanisms and the diagnostic utility of cytokines and acute phase proteins in traumatic injuries, pediatric food allergies, inflammatory bowel disease, and melanoma. Her earlier investigations examined immune system dysfunctions in mental disorders, inflammation-related biomarkers in metabolic diseases, and the application of immunodiagnostic monitoring in veterinary medicine. Furthermore, her research has enriched knowledge of rheumatic diseases through the analysis of inflammatory markers and glycosylation profiles. International training at leading immunology and rheumatology centers strengthened her expertise in how physiotherapy modulates inflammation and acute phase responses. Dr. Sobieska maintains an extensive teaching portfolio, encompassing immunology, biochemistry, sport immunology, spa medicine, diagnostic methods in rheumatology, and laboratory medicine for physiotherapy students. Her commitment to education is reflected in her long-standing mentorship of graduate students, with numerous bachelor’s and master’s theses completed under her supervision. Her scholarly influence is well documented, with 2,189 citations across 1,869 documents, a publication record of 117 scientific works, and an h-index of 20, underscoring the sustained impact of her research within the scientific community. Fluent in multiple European languages, she brings multicultural and multilingual strength to collaboration and academic engagement. Her comprehensive background and broad expertise position her as a respected educator, researcher, and mentor in the medical and rehabilitation sciences.

Profiles: Scopus | Orcid

Featured Publications

Gajewska, E., Surowińska, J., Michalak, M., Gajewski, J., Chałupka, A., Naczk, M., Naczk, A., & Sobieska, M. (2025). The third month’s development predicts the side and oblique sit and walking. Journal of Clinical Medicine, 14, Article 38492. https://doi.org/10.3390/jcm14238492

Pawlak-Andryszczyk, Ż., Andryszczyk, M., & Sobieska, M. (2025). Movements induced by optic flow in relation to HINE. Scientific Reports, 15, Article 20726. https://doi.org/10.1038/s41598-025-20726-y

Bieniaszewska, A., Sobieska, M., & Gajewska, E. (2024). Functional and structural changes in patients with spinal muscular atrophy treated in Poland during 12-month follow-up: A prospective cohort study. Journal of Clinical Medicine, 13(14), 4232. https://doi.org/10.3390/jcm13144232

Bieniaszewska, A., Sobieska, M., Steinborn, B., & Gajewska, E. (2023). Examination of upper limb function and the relationship with gross motor functional and structural parameters in patients with spinal muscular atrophy. Biomedicines, 11(4), 1005. https://doi.org/10.3390/biomedicines11041005

De Mezer, M., Rogaliński, J., Przewoźny, S., Chojnicki, M., Niepolski, L., Sobieska, M., & Przystańska, A. (2023). SERPINA3: Stimulator or inhibitor of pathological changes. Biomedicines, 11(1), 156. https://doi.org/10.3390/biomedicines11010156

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Published on by Invention Awards

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.